Earnings Scheduled For February 28, 2022
Companies Reporting Before The Bell
• Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter.
TaskUs Issues Response To Short Seller, Says Recent Report Contains ‘numerous inaccuracies and mischaracterizations of our business and future prospects’
TaskUs, Inc. (NASDAQ:TASK), a leading tech-enabled services provider to the world’s most innovative companies, issued the following statement:
The Company and Board are aware of the recent report published by a
Mid-Afternoon Market Update: Dow Surges 300 Points; Luminar Technologies Shares Spike Higher
Toward the end of trading Thursday, the Dow traded up 0.88% to 35,336.29 while the NASDAQ rose 1.33% to 14,530.74. The S&P also rose, gaining, 1.02% to 4,579.15.
Mid-Day Market Update: Crude Oil Rises 1%; China Finance Online Shares Slide
Midway through trading Thursday, the Dow traded up 1.04% to 35,392.40 while the NASDAQ rose 1.59% to 14,568.72. The S&P also rose, gaining, 1.20% to 4,587.08.
38 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Baudax Bio, Inc. (NASDAQ: BXRX) shares rose 29.8% to $0.2550. Baudax Bio, last month, announced a $4.2 million registered direct offering.
Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning trading, 152 companies set new 52-week lows.
Goldman Sachs Initiates Coverage On TaskUs with Buy Rating, Announces Price Target of $77
Goldman Sachs analyst Brian Essex initiates coverage on TaskUs (NASDAQ:TASK) with a Buy rating and announces Price Target of $77.